$TRIB with all the excitement about TRIB's Covid products let's not forget another of their pipeline Trinscreen an HIV screening product for the African market (TRIB estimated the market at $150m in 2018). trinitybiotech.com/wp-conte... Here's what the CEO said at Q3ER: So, we have submitted all of the modules with WHO, and approval of Trinscreen, with the exception of the actual clinical trials themselves. And what's happened there is that they basically have been stalled because of COVID ... My estimate at this stage is that they will be into the market by the middle -- certainly by quarter three of 2021 with Trinscreen. And so, I'm -- when looking at something like a quarter one submission of the final ... piece for clinical trial data to WHO, and then expecting the approval within four or five months. But that comes with a warning, just relating to -- it's still difficult to get trials done at the moment in hospitals.
3
3
3 Likes